UEG's educational platform for gastroenterology education bringing recordings, courses, guidelines, and more together in one place.
Most popular content
Rate for better recommendations!
Your feedback helps us show you more of what you like and less of what you dislike!
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
IMPROVEMENT IN INTESTINAL IMMUNE ACTIVATION, PERMEABILITY AND SENSITIVITY WITH LOCAL BUDESONIDE IN A VALIDATED MODEL FOR DISORDERS OF GUT-BRAIN INTERACTION
Pauline Huyghe 1, Alison Accarie 1, Mathieu Meleine 1, Karen Van den Houte 1, Joran Toth 1, Lucas Wauters 2, Jan Tack 2, Ricard Farré 1, Tim Vanuytsel 2
1 KU Leuven, Leuven, Belgium
2 University of Leuven, University Hospital Gasthuisberg, Leuven, Belgium|||KU Leuven, Leuven, Belgium
Event
Topics
Submission format
Citation
Published
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
Who is at risk: Is it all about anticoagulants?
1 Valduce Hospital, Como, Italy
Event
Topics
Session
Citation
Published
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
GP: First line diagnosis and treatment
1 European Society for Primary Care Gastroenterology (ESPCG), Sant Adrià de Besòs ( Barcelona), Spain
Event
Session
Citation
Published
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
Exploiting the immune response in GI cancer: Next chapter
1 CHU de Nantes IMAD, Nantes, France
Event
Topics
Citation
Published
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
The future of MASLD
1 Innsbruck Medical University - Department of Medicine, Innsbruck Medical University; Innsbruck/AT, Innsbruck, Austria
Event
Topics
Citation
Published
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
When to think about gastroparesis and what to do
1 Institute for Clinical and Experimental Medicine Gastroenterology & Hepatology, Praha, Czech Republic
Event
Session
Citation
Published
Log in to access this content.
Free for all myUEG account holders. Your access level is set automatically based on your occupation. Medical professionals get full access to all content. If you are a non-medical user, you can only access UEG Week content from congresses you attended.
Not sure what you can access? Learn more about account types.
A NOVEL MULTI-EPITOPE BASED VACCINE AGAINST HELICOBACTER PYLORI
Behnam Kalali 1, Hassan Moeini 1, Amrollah Mostafazadeh 2, Abbas Yadegar 3, Volker Wedershoven 4, Christian Schulz 5, Peter Malfertheiner 5
1 Iguana Biotechnology, Munich, Germany|||Ludwig Maximilian University, Munich, Germany
2 Babol University of Medical Sciences, Babol, Iran, Islamic Republic of
3 Shahid Beheshti Medical University, Tehran, Iran, Islamic Republic of
4 Iguana Biotechnology, Munich, Germany
5 Ludwig Maximilian University, Munich, Germany
Event
Submission format
Session